CTRI/2017/06/008847
Recruiting
Phase 4
Real world Non-interventional Observational Study of Hydroxyzine hydrochloride in Chronic Pruritus
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Chronic Pruritus
- Sponsor
- Dr Reddys Laboratories Ltd
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients clinically diagnosed with chronic pruritus due to dermatological conditions where physician has taken decision to prescribe hydroxyzine hydrochloride.
- •2\. Patients aged 18 years to 50 years who provide informed consent for data collection.
- •3\. Patients of both sexes.
Exclusion Criteria
- •1\. Patients with chronic pruritus due to systemic causes.
- •2\. Patients with known hypersensitivity to hydroxyzine hydrochloride or any component of this medication.
- •3\. Females who are pregnant or are lactating.
- •4\. Patients on other CNS medications, or known neurological conditions.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical trial to observe the safety and effectiveness of acotiamide in patients with functional dyspepsiaCTRI/2017/11/010421Dr Reddys Laboratories Limited
Completed
Not Applicable
Study of Venusia® Max Cream as Moisturizer in PsoriasisHealth Condition 1: null- PsoriasisCTRI/2017/03/008023Dr Reddys Laboratories Ltd400
Not yet recruiting
Not Applicable
Study to analyse usefulness of antibacterial (Chlorhexidine) containing mouthwash for the treatment of swollen and bleeding gums.Health Condition 1: K051- Chronic gingivitisCTRI/2019/04/018353Dr Reddys Laboratories Ltd
Completed
Not Applicable
ongitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ® in adults and GRAZAX® and SLIToneULTRA® in adults and children (5 – 17 years) in patients with allergic Rhinoconjunctivitis in GErmanyJ30.1J30.3Allergic rhinitis due to pollenOther allergic rhinitisDRKS00005069ALK-Abelló Arzneimittel GmbH2,571
Completed
Not Applicable
An observational study to assess the usefulness of Eberconazole cream (Ebernet®) in patients with tinea (fungal) infectioCTRI/2019/05/019449Dr Reddys Laboratories Ltd120